New drug cocktail aims to shrink head and neck tumors before surgery
Disease control
ENROLLING_BY_INVITATION
This study tests whether combining two drugs, pertuzumab and lenvatinib, can shrink advanced head and neck cancers before surgery. About 30 adults with newly diagnosed, locally advanced squamous cell carcinoma will receive the drug combination before their operation. The goal is …
Phase: PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC